194 related articles for article (PubMed ID: 34865056)
1. Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.
Cote DJ; Kilgallon JL; Nawabi NLA; Dawood HY; Smith TR; Kaiser UB; Laws ER; Manson JE; Stampfer MJ
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1402-e1412. PubMed ID: 34865056
[TBL] [Abstract][Full Text] [Related]
2. Alcohol intake and risk of pituitary adenoma.
Cote DJ; Smith TR; Kaiser UB; Laws ER; Stampfer MJ
Cancer Causes Control; 2022 Feb; 33(2):353-361. PubMed ID: 34982318
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study.
Heuch I; Heuch I; Hagen K; Storheim K; Zwart JA
BMC Musculoskelet Disord; 2023 Jan; 24(1):84. PubMed ID: 36721124
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.
Lu Y; Wang SS; Sullivan-Halley J; Chang ET; Clarke CA; Henderson KD; Ma H; Duan L; Lacey JV; Deapen D; Bernstein L
Int J Cancer; 2011 Aug; 129(4):974-82. PubMed ID: 20957632
[TBL] [Abstract][Full Text] [Related]
5. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
7. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
Colditz GA
Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
[TBL] [Abstract][Full Text] [Related]
9. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
10. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
12. Association of oral contraceptives and tubal ligation with risk of early natural menopause.
Langton CR; Whitcomb BW; Purdue-Smithe AC; Sievert LL; Hankinson SE; Manson JE; Rosner BA; Bertone-Johnson ER
Hum Reprod; 2021 Jun; 36(7):1989-1998. PubMed ID: 33822044
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
14. Body Habitus Across the Lifespan and Risk of Pituitary Adenoma.
Cote DJ; Smith TR; Kaiser UB; Laws ER; Stampfer MJ
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1591-e1602. PubMed ID: 33417714
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
Morois S; Fournier A; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC
Eur J Epidemiol; 2012 Jun; 27(6):439-52. PubMed ID: 22644109
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
17. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of oral contraceptive use and colorectal adenomas.
Charlton BM; Giovannucci E; Fuchs CS; Chan AT; Lee JE; Cao Y; Missmer SA; Rosner BA; Hankinson SE; Willett W; Wu K; Michels KB
Cancer Causes Control; 2016 Jun; 27(6):749-57. PubMed ID: 27125831
[TBL] [Abstract][Full Text] [Related]
19. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
[TBL] [Abstract][Full Text] [Related]
20. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
